BALAXI PHARMACEUTICALS
Back to Balance Sheet
|
BALAXI PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | - | - | - | - | - |
What is the latest Contingent Liabilities ratio of BALAXI PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | - |
How is Contingent Liabilities of BALAXI PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Contingent Liabilities of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹159.5 Cr | -2.4% | -25% | -64.9% | Stock Analytics | |
| ADANI ENTERPRISES | ₹290,576.0 Cr | 0.8% | -6.5% | -6% | Stock Analytics | |
| REDINGTON | ₹21,502.7 Cr | 1.3% | -3.6% | 31% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹10,612.6 Cr | 13% | 22.2% | 62.6% | Stock Analytics | |
| HONASA CONSUMER | ₹8,846.8 Cr | 2% | -7% | 7.2% | Stock Analytics | |
| MMTC | ₹8,601.0 Cr | 3% | -9.7% | -28% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -2.4% |
-25% |
-64.9% |
| SENSEX | 1% |
0.3% |
6.7% |
You may also like the below Video Courses